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Abstract
Introduction Conventional MRI may still be an inaccu-
rate method for the non-invasive detection of a micro-
adenoma in adrenocorticotropin (ACTH)-dependent
Cushing’s syndrome (CS). Bilateral inferior petrosal sinus
sampling (BIPSS) with ovine corticotropin-releasing
hormone (oCRH) stimulation is an invasive, but accurate,
intervention in the diagnostic armamentarium surround-
ing CS. Until now, there is a continuous controversial
debate regarding lateralization data in detecting a micro-
adenoma. Using BIPSS, we evaluated whether a highly
selective placement of microcatheters without diversion
of venous outflow might improve detection of pituitary
microadenoma.
Methods We performed BIPSS in 23 patients that met
clinical and biochemical criteria of CS and with
equivocal MRI findings. For BIPSS, the femoral veins
were catheterized bilaterally with a 6-F catheter and the
inferior petrosal sinus bilaterally with a 2.7-F micro-
catheter. A third catheter was placed in the right femoral
vein. Blood samples were collected from each catheter to
determine ACTH blood concentration before and after
oCRH stimulation.
Results In 21 patients, a central-to-peripheral ACTH
gradient was found and the affected side determined. In
18 of 20 patients where transsphenoidal partial hypophy-
sectomy was performed based on BIPSS findings, micro-
adenoma was histologically confirmed. BIPSS had a
sensitivity of 94% and a specificity of 67% after oCRH
stimulation in detecting a microadenoma. Correct localiza-
tion of the adenoma was achieved in all Cushing’s disease
patients.
Conclusion BIPSS remains the gold standard in the
detection of a microadenoma in CS. Our findings show
that the selective placement of microcatheters without
venous outflow diversion might further enhance better
recognition to localize the pituitary tumor.
Keywords Angiography, Digital subtraction . Cushing
disease . Petrosal sinus sampling . Pituitary gland .Magnetic
resonance imaging
Introduction
Cushing’s syndrome (CS) is a hormonal disorder charac-
terized by an increase in circulating cortisol. Endogenous
hypercortisolism may be adrenocorticotropin (ACTH)
dependent (pituitary or an ectopic source) or independent
(related to the anatomy of the adrenal glands) [1, 2].
ACTH-dependent pituitary disease (Cushing’s disease, CD)
is responsible for about two thirds of Cushing’s syndrome
[3–5]. It is most frequently caused by a microadenoma
(diameter<10 mm) [5, 6], less frequently by a macro-
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adenoma (diameter>10 mm) or hyperplasia of corticotro-
phin cells [5, 7, 8], and rarely by carcinoma of the pituitary
gland [9–11]. In contrast to pituitary-dependent CS, ectopic
CS is a rare condition [12].
Differentiating between CD and ectopic ACTH syn-
drome (EAS) is a diagnostic challenge as they show similar
clinical and biochemical features [13]. Due to the small
size, a pituitary lesion can only be detected in about 50% of
imaging studies [12, 14–17]. Furthermore, the differential
diagnosis of a pituitary incidentaloma vs. an ACTH-
secreting microadenoma can be challenging [13, 18, 19].
Since the majority of patients with CD can be treated by
transsphenoidal microsurgery and has a remission rate of
80–90% [5], it is critical to confirm the pituitary etiology of
hypercortisolism and precisely localize the pituitary micro-
adenoma preoperatively.
Digital imaging studies are often not sufficient for the
unambiguous identification of microadenomas; both com-
puterized tomography (CT) and magnetic resonance imag-
ing (MRI) with standard sequences have a rather low
sensitivity for these tumors: CT scan 15–60% [20, 21] and
MRI 60%, respectively [22]. Conventional spin echo
gadolinium-enhanced MRI with fine cuts through the sella
turcica is nevertheless indicated in all patients with ACTH-
dependent Cushing syndrome [13, 23] and allows detection
of a discrete adenoma in 50% to 60% of patients [22].
Spoiled gradient-recalled acquisition sequences can
increase this sensitivity to approximately 80% [4]. Dynamic
contrast-enhanced MRI may improve imaging accuracy
[24–26] given that adenomas in comparison to normal
pituitary gland parenchyma tend to be slowly enhancing.
Furthermore, coronal postcontrast SPGR-MRI images
showed to better differentiate microadenoma than conven-
tional SE-MRI imaging protocols of the pituitary gland in
patients with suspected Cushing disease [27]. Recently,
Portocarrero et al. showed that a half-dose gadolinium
protocol in dynamic 3-T MRI may further increase the
sensitivity of MRI detection of ACTH-secreting pituitary
tumors [28]. Nevertheless, false-negative MR results due to
microadenomas that are still too small to detect by current
imaging are common. In addition, approximately 10% of
the normal population without any symptoms had inciden-
talomas in radiological series [29]. Therefore, bilateral
inferior petrosal sinus sampling (BIPSS) before and
following corticotropin-releasing hormone (oCRH) stimu-
lation remains the gold standard to distinguish CD from
EAS [30, 31]. This procedure is included in the diagnostic
algorithm for CS in current guidelines [32]. Whether BIPSS
is capable to localize the correct side of the pituitary
adenoma—in addition to confirm the central etiology of
hypercortisolism—remains a controversial issue [33–35].
Thus, the aim of the current study was to evaluate the
influence of microcatheters for the petrosal sinus sampling
without flow diversion in the accurate detection of the
origin of ACTH secretion.
Material and methods
Study patients
We retrospectively analyzed the accuracy of a highly
selective placement of microcatheters without diversion of
venous outflow in patients with Cushing syndrome and
ambiguous conventional MRI findings, who were referred
to our institution from June 1997 to January 2010. All
patients fulfilled the diagnostic criteria of Cushing’s
syndrome, specifically the clinical features, biochemical
tests with measurement of plasma cortisol, 24-h free
cortisol in the urine, ACTH values, and a high-dose
dexamethason suppression test before BIPSS.
Study procedures
Magnetic resonance imaging
In all patients, a pituitary conventional 1.5-T MRI was
performed. The standard protocol included a PD/T2-weighted
whole-brain study with 5-mm slice thickness.
Both unenhanced and contrast-enhanced overlapping
3 mm studies in sagittal and coronal plane over the sellar
region were conducted.
BIPSS
BIPSS was performed when the MRI was suspected as
normal or inconclusive for a pituitary process and when the
biochemical results indicated Cushing’s disease.
Twenty patients were examined using neuroradiological
angiography with a biplane system; in three patients, the
angiographic examination was conducted using an Axiom
Artis Zee including 3D rotational angiography. All procedures
were performed by two senior interventional neuroradiologists.
In all but one patient, local anesthesia at the femoral
puncture sites was used prior to the BIPSS procedure. In
patient no. 13, general anesthesia was required because of
the young age at examination date. The femoral veins were
catheterized bilaterally with a 6-F catheter and heparin was
used in the flushing fluid for systemic anticoagulation. The
tips of these catheters were placed in the internal jugular
veins. The 2.7-F microcatheters were guided under fluoro-
scopic control into both petrosal sinuses. This was possible
in 15 out of 16 patients; however, in one case, the right
catheter remained in the proximal internal jugular vein. The
pattern of venous drainage was determined on each side
after contrast injection. The venous drainage of the petrosal
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sinus in the jugular vein was classified as one of five
drainage patterns including four common variants [36] and
a fifth rather rare variant [37], where the inferior petrosal
sinus connects far below the jugular bulb into the jugular
vein (Figs. 1 and 2).
In seven patients, the exact type of venous drainage
could only be identified from the written report because of
loss of the angiography films. The position of the catheter
tip was controlled before and after the venous sinus petrosal
sampling (Fig. 3).
Venous blood was sampled simultaneously from both
petrosal sinuses and the peripheral vein. Two baseline
values were taken followed by the administration of a
bolus of oCRH (1 μg/kg body weight). In all three
catheters, i.e., both petrosal sinuses and the peripheral
vein, venous blood was sampled simultaneously for the
measurement of ACTH at 3, 5, and 10 min after oCRH
injection.
After the procedure, patients were observed neurologi-
cally for 24 h in our department.
ACTH gradients
The average ratio of ACTH values before and after oCRH
administration was used to calculate the gradients needed
for detecting the source of cortisol depletion. A central-to-
peripheral gradient ≥2.0 at baseline, or ≥3.0 after oCRH
stimulation was regarded as indicating a pituitary source of
ACTH production according to Oldfield et al. [31]. An
intersinus gradient ≥1.4 was evidence of right–left lateral-
ization, an intersinus gradient <1.4 showed either bilateral
disease or a midline lesion [38].
Results
Patients
Briefly, the study included 23 patients (18 women, five
men; mean age 47 years, age range 7–70 years). A full
description of the study patients can be found in Table 1.
MRI studies
In eight out of the 23 patients, MRI identified the
microadenoma correctly compared with the histopatho-
logical findings after surgery as standard of reference
(patient no: 1, 4, 7, 8, 17, 18, 22, and 23). In one patient
(no. 6), a pituitary adenoma was recognized by MRI but
the side of the pathologic process could not be
identified. The pituitary was correctly recognized as
normal (true-negative result) in two patients (no. 3 and
14). In 12 patients, a false result was identified. There
were four false-positive findings (no. 2, 9, 11, and 15)
and eight false-negative results (cases 5, 10, 12, 13, 16,
19, 20, and 21). These findings resulted in 52.9%
sensitivity and 33.3% specificity for MRI to detect a
pituitary microadenoma compared with the histopatho-
logcial findings.
Catheterization procedure
The variants of the venous drainage that describe the
pattern of flow from the petrosal sinus into the jugular vein
are shown in Figs. 1 and 2. Twenty-one of 23 patients were
correctly diagnosed by BIPSS in terms of the central to
peripheral gradient. In all cases with a central lesion, a
correct lateralization was made. However, in one patient
(no. 17) the required value of 1.4 after oCRH stimulation
was marginally beneath the required cut-off, namely 1.339,
yet we decided to take this result as sufficient for the
lateralization.
In patient no. 3, the result of the central to peripheral
gradient showed a false-positive value compared with the
histopathological result. In the latter, no microadenoma
could be identified postoperatively, therefore an adrenalec-
tomy was performed.
Patient no. 4 (false-negative result) had a central to
peripheral vein ratio less than needed for the diagnosis of
CD. Nevertheless, pituitary surgery was performed because
of a strong clinical suspicion of CD and an MRI result that
revealed a suspicious pathological intrasellar lesion inter-
preted as a microadenoma on the right side. At surgery, a
Fig. 1 Schematic representation
of the variations of inferior
petrosal sinus drainage into the
internal jugular vein: types 1–4
modified after Shiu et al. [36]
and type 5 variant described by
Benndorf and Campi [37]
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small tumor was found and histopathologically confirmed
(Table 1).
Of the 20 patients with CD, a central to peripheral
gradient suggesting CD was already obtained before oCRH
in 17 patients, two additional patients showed a gradient
greater than 3.0 after CRH application (no. 10 and 15). In
one patient (no. 4), a false-negative result was obtained (see
previous description above).
Three patients showed an ectopic localization of the
ACTH source regarding BIPSS result (no. 2, 4, and 14):
patient no. 2 and 14 showed a true-negative result whereas
patient no. 4 had a false-negative result. In the CD group of
20 patients, an intersinus gradient >1.4 was found (16
patients before oCRH application and in four patients after
(no. 10, 17, 22, and 23)).
No serious complications occurred during and after the
invasive procedure.
Surgical technique
In 20 patients with suspected CD as a result of BIPSS,
transsphenoidal surgery for adenoma extirpation was
performed. Briefly, surgery was performed via a unilateral
transseptal transsphenoidal approach while in the semi-
sitting position. Above all, especially in cases where a
hyperplasia in the histological examination was found, the
intraoperative adenoma tissue was frequently difficult to
differentiate or a suspicious brighter tissue could be
demarcated. In these cases, according the result of BIPSS,
one third of the lateral adenoma tissue was extirpated.
Afterwards, the cavity was filled with gelatin foam soaked
in fibrin glue, and the sellar opening was covered with a
Fig. 2 Angiography of drainage variant type 5. Uncommonly low
origin of the inferior petrosal sinus from the right jugular vein on the
right side. The intercavernous sinus is depicted as well. Awareness of
this infrequent venous pattern may help to better identify the
successful approach to the cavernous sinus
Fig. 3 BIPSS procedure. A
Digital subtraction angiography
of the inferior petrosal sinus
shows 6-F guiding catheters in
the internal jugular veins (white
arrows) and 2.7-F microcath-
eters in the petrosal sinuses
(black arrows). B Similar an-
giogram as shown in (A) with
simultaneous contrast filling of
both inferior petrosal sinus as
well as the intercavernous sinus.
Images (C and D) depict the
same venous pattern in a 3D
rotational angiography
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synthetic absorbable vicryl patch as described in the
literature [39].
Histopathological results
In the 20 patients where a central adenoma was suspected
using BIPSS, a transsphenoidal surgery was performed.
Hyperplasia of ACTH-producing cells or an adenoma was
observed in 18 of the 20 histopathological samples. In one
patient (no. 13), a histological evaluation was not made
because of loss of the histological material.
In the patient with highly suspected CD, gamma knife
irradiation of the pituitary gland was performed and the
patient had a favorable outcome.
In the three patients with an ectopic source of ACTH
expression (no. 2, 4, and 14), histology confirmed the
localization of ACTH expression: one patient (no. 2) had
a lung lobe resection and ACTH expression was
identified by histology, another patient had a double-
sided adrenalectomy (no. 14) causing a remission, and
the treatment of the third patient (no. 4, false-negative
result) has been previously discussed. Of note, histopath-
ological confirmation of an ACTH-secreting adenoma
strongly correlates with remission [40].
Clinical outcomes
The clinical outcome of the 23 patients analyzed with
BIPSS was favorable in the majority of cases: 15 patients
showed postoperative normalization of the hypercortisolism
with favorable clinical development, one patient showed
partial regression (no. 14), and three patients showed no
remission (no. 6, 11, and 16). Two patients had a gamma
knife treatment with no available long-term result to date
(no. 5 and 13). Patient no. 3 had adrenalectomy because the
BIPSS results revealed a pituitary process, but surgery
showed no adenoma and finally, patient no. 8 had a
reoperation because of a residual adenoma of the pituitary.
Statistical analyses
The BIPSS procedure allowed the correct differentiation
between CD and EAS in 82.4% and 95.0% of patients
before and after oCRH stimulation, respectively. The
specificity of the BIPSS procedure before and after oCRH
stimulation was 66.7% respectively. Correct lateralization
could be made in all cases of CD (100%).
Discussion
There is considerable controversy in regards to the accuracy
of the side of pituitary lesion using BIPSS data [41]. In the
present study, BIPSS was able to correctly localize the side
of the adenoma in all patients with CD. Of the examined 20
patients with CD, an intersinus gradient >1.4 was achieved
in 80% of the cases before and in 100% after oCRH
stimulation even if an asymmetric venous drainage was
documented. This is consistent with the study of Oliverio et
al. [42]. They reported in a series of 17 patients that
bilateral cavernous sinus sampling (BCSS) enabled the
identification of the correct side in all patients, yielding a
positive predictive value of 100%. The author concluded
that this result might be due to the potential of cavernous
sinus sampling to more accurately lateralize the lesion.
However, Doppman et al. [43] reported correct lateraliza-
tion in patients with CD using BIPSS in 60% of the cases
without and in 73% of the cases with oCRH stimulation.
Newell-Price et al. [34] found that CD can be distinguished
from EAS with a diagnostic accuracy close to 100% when
BIPSS is combined with oCRH stimulation. On the other
hand, the intersinus gradient correctly predicted the
localization of the pituitary adenoma in only 78% of the
cases.
These controversial findings may be related to the
different venous drainage pattern [41]. Lefournier et al.
[44] reported that three parameters influenced the laterali-
zation result, i.e., venous drainage pattern, sampling site,
and oCRH stimulation. Friedman et al. [45] performed the
procedure in adults with CD and healthy volunteers and
found that the correct lateralization side was the side of the
dominant petrosal sinus.
However, in the current study asymmetric venous
drainage did not influence the lateralization data. Due to
the fact that we detected 80% accuracy before and 100%
accuracy after stimulation, we assume that compensatory
and regulatory mechanism on the contra-lateral side of the
adenoma may have influenced the hormone levels. Fur-
thermore, for all patients we selectively placed the micro-
catheter in the petrosal sinus, which does not disturb the
venous blood flow in both petrosal sinus and the cavernous
sinus. In contrast, the placement of catheters with relatively
large diameter influences the drainage pattern by obstruct-
ing the venous outflow around the catheter. This may result
in retrograde blood flow through the intercavernous sinus
leading to false-positive values on the opposite side of the
lesion. In addition, digital subtraction angiography was
performed to assure the correct catheter placement and to
document the anatomical venous pattern drainage. Micro-
catheters allow a normal blood flow without influencing the
venous blood flow even in asymmetric drainages. This also
may minimize complications such as thromboembolism or
perforations. We conclude that the use of microcatheters
result in significantly improved measured ACTH concen-
trations on the effective side of the lesion. We propose that
digital subtraction angiography should be performed to
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assure the correct catheter placement for documenting the
exact anatomical venous pattern drainage. This allows for a
critical and comprehensive analysis of the anatomy with the
obtained biochemical cortisol levels.
Additionally, it is established that the diagnostic perfor-
mance of BIPSS is superior to pituitary imaging in ACTH-
dependent hypercortisolism to distinguish between CD and
ectopic ACTH-dependent hypercortisolism. The current
findings are consistent with previous results [30, 31, 46,
47] showing a superior sensitivity and specificity of BIPSS
compared with MRI (95% to 52.9% and 66.7% to 33.3%,
respectively). Most pituitary macroadenomas can be
detected by MRI. CD, however, is mostly caused by
microadenomas so that it is often difficult or even
impossible to determine a pathologic intrasellar process.
There were no severe complications in the current study
suggesting that this invasive procedure is safe in experi-
enced hands. However, in previous studies several major
complications such as pulmonary thromboembolism [15,
41, 42] and lower extremity deep venous thrombosis [48]
have been reported. In addition, Lefournier et al. [44]
described two cases of transient sixth cranial nerve palsy
during BCSS. They attributed these incidents to the guide
wire of the catheter and suggest that BCSS might be less
safe than BIPSS. Graham et al. [49] performed cavernous
sinus sampling (CSS) with 2.7-F microcatheters and
compared it with results of inferior petrosal sinus sampling.
They found that CSS was superior to IPSS for intrapituitary
tumor localization and no complication occurred in their
series of 70 patients. Recent results suggest that BIPSS is
not inferior to BCSS with regard to correct lateralization of a
microadenoma. This view is consistent with the studies of
Doppman [43], Mamelak [41], and Lefournier [44]. In a
recent study published by Gandhi et al. [50], one serious
complication of irreversible brain stem injury in a study of
44 patients who underwent BIPSS for evaluation of
Cushing’s disease was described. In this rare case, there
was radiographic evidence of venous outflow variance that
may have contributed to the injury. They concluded that
venous hypertension as a result of catheter-related occlusion
of a venous channel or from the pressure or toxicity of
contrast injection probably resulted in the pontine infarction.
Study limitations
In seven out of 23 subjects, no angiogram films were
available so that the type of drainage had to be estimated
from the written report which limits exact reconfirmation of
catheter position.
We had no control group in our study comparing
selective catheterization versus a more proximal non-
selective venous blood sampling. This would allow direct
comparison of the influence of microcatheters in this
specific setup and would also be technically possible;
however, two major concerns limit this approach. First,
measurement of ACTH concentrations 3, 5, and 10 min
after oCRH stimulation had to be measured two times with
an already attained peak of ACTH concentration after the
first stimulation. Second, prolonged catheter placement in
the venous system bears the danger of possible thrombus
formation with consecutive thromboembolism even under
continuous heparin infusion during the procedure. Addi-
tionally, our patient collective still represents a relatively
small sample and would not be definitive.
Conclusion
BIPSS remains the gold standard in the detection of a
microadenoma in CS. Supporting selective placement of
microcatheters without venous outflow diversion may play
an important role in accurate detection of the origin of
ACTH secretion. Therefore, this super-selective catheteri-
zation technique provides a firm basis in the assessment of
CS caused by a non-detectable microadenoma of the
pituitary.
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